グローバルニューロテクノロジーデバイス市場規模、主要企業シェア、ランキング分析レポート【2026年版】
Neurotechnology Device - Global Top Players Market Share and Ranking 2026

- レポートID:188742
- 発表時期:2026-02-06
- レポート形式:PDF
- 産業カテゴリー:医療機器と消耗材
- レポート言語:英語、日本語
- ページ数:111
- 発行会社(調査会社):YHResearch
言語とエディションの価格
- 英語版
- 日本語版
- 英語と日本語版
個人版詳細
マルチユーザー版詳細
企業版詳細
- 英語版
- 日本語版
- 英語と日本語版
価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=158.00円。
※米ドル表示価格+10%消費税。
※ご注文方法:お問い合わせフォームまたはメールにてご連絡ください。
支払方法:「銀行振込」の場合, 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期:原則として、受注後2~4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8~10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。
レポートの概要
本報告書は、世界のニューロテクノロジーデバイス市場について包括的な分析を行い、市場全体の動向を明らかにすることを目的としています。総販売数量、売上高、価格動向に加え、主要企業の市場シェアおよび順位を整理し、市場構造を多角的に把握します。さらに、地域・国別、製品タイプ別、用途分野別などの観点からニューロテクノロジーデバイス市場を分析し、需要構造と成長特性を明確化します。
ニューロテクノロジーデバイス市場の規模、推定値および予測は、2025年を基準年とし、2021年から2032年までの期間における販売数量および売上高に基づいて提示しています。定量分析と定性分析を組み合わせることで、ビジネスおよび成長戦略を検討し、市場競争環境を評価し、企業の市場ポジションを把握した上で、ニューロテクノロジーデバイスに関する的確な意思決定を行うための実践的なインサイトを提供します。
主要ニューロテクノロジーデバイス市場の統計
2025年世界市場規模:14330百万米ドル
2026年世界市場規模:15310百万米ドル
2032年予測市場規模:23160百万米ドル
2026–2032年予測期間CAGR:7.1%
本レポートはニューロテクノロジーデバイス市場の中長期的な成長動向を定量分析および定性分析の両面から体系的に整理しています。
【市場セグメンテーション】
主要企業・競争環境
ニューロテクノロジーデバイス市場の主要企業には以下が含まれます:
Abbott Laboratories
Advanced Bionics
Axonics Modulation Technologies
Boston Scientific Corp
Laborie
Cleveland Medical Devices
EndoStim
LivaNova
Medtronic
Natus Medical Incorporated
Neuronetics
NeuroSigma
Restorative Therapies
Zynex Medical
Cochlear Limited
製品別
Neuroprosthetics
Neural Stimulators
Neurorehabilitation
Neurosensing
アプリケーション別
Parkinson's Disease
Cerebral Palsy
Cognitive Disorders
Epilepsy
Incontinence
Traumatic Brain Injury
Others
レポート対象地域
北米:アメリカ、カナダ、その他
アジア太平洋:中国、日本、韓国、東南アジア、インド、オーストラリア、その他
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、オランダ、北欧諸国、その他
ラテンアメリカ:メキシコ、ブラジル、その他
中東・アフリカ:トルコ、サウジアラビア、UAE、その他
レポート構成(章別概要)
第1章|市場概要と成長展望
ニューロテクノロジーデバイス市場の全体像を整理し、市場規模、売上予測、価格推移を体系的に解説します。同時に成長要因、市場機会、業界課題、リスク要因を分析し、中長期的な市場展望を提示します
第2章|主要企業の競争分析
ニューロテクノロジーデバイス市場における主要プレイヤー(トップ5社・トップ10社)を対象に、売上高、製造拠点、製品構成、価格戦略、販売量、市場シェアを多面的に分析し、競争構造を明確化します
第3章|製品カテゴリ別市場動向
製品タイプ別にニューロテクノロジーデバイス市場を分類し、売上高、市場シェア、販売量、価格動向を分析します。成長性の高い製品分野と市場構造の変化を明らかにします
第4章|用途別市場動向
用途別にニューロテクノロジーデバイス市場規模、売上高、市場シェア、販売量、価格推移を整理し、業界別の需要動向と成長ポテンシャルを分析します
第5章|地域別市場分析
地域別の市場成長率、販売量、売上高を詳細に分析し、ニューロテクノロジーデバイス市場の地理的需要構造を可視化します。各地域の市場規模推移と将来の成長余地を評価します
第6章|国別市場動向
主要国・地域ごとに、ニューロテクノロジーデバイス市場の販売量、売上高、成長要因、政策・規制環境、競争特性を整理し、国別市場の特徴を明確にします
第7章|主要企業プロファイル
ニューロテクノロジーデバイス市場を牽引する主要企業について、売上高、販売量、価格動向、粗利益率、製品ポートフォリオ、最新の戦略動向を詳細に解説します
第8章|バリューチェーンと市場構造分析
業界全体のサプライチェーンを上流から下流まで整理し、コスト構造や流通モデルの動向を分析します
第9章|調査結果
調査結果を総括し、市場全体のトレンド、今後の成長機会、潜在的リスク、戦略的な洞察を提示します
第10章|付録(調査手法・データソース)
調査設計、分析手法、使用データソースの詳細を明示し、レポートの信頼性と透明性を担保します
本レポートの要点と洞察
ニューロテクノロジーデバイス市場の全体像と成長見通し
ニューロテクノロジーデバイス市場の規模変化の傾向、成長予測及び需要動向を体系的に整理いたします。2021年から2025年までの実績データに基づき、2032年までの中長期予測を提示し、市場の拡大速度と成長潜在力を明らかにします。同時に、最近の関税調整措置など各国の政策動向を踏まえ、多角的にグローバル経済環境がニューロテクノロジーデバイス市場に与える影響を分析いたします
市場環境の構成要素とマクロトレンド
ニューロテクノロジーデバイス産業を取り巻く市場環境について、需要構造の変化、政策対応、技術革新の進展といった主要要因を整理します。特に、国際貿易政策や関税政策の変化が企業戦略や価格形成に及ぼす影響、サプライチェーン再編の動きと事業運営への波及効果を明確化し、市場環境の全体像を包括的に提示します
競争構造と主要企業の動向分析
ニューロテクノロジーデバイス市場における主要企業の売上規模、市場シェア、競争ポジションを整理し、競争構造の特徴を分析します。各社の競争戦略、事業拡大の方向性、新製品・新技術の投入動向を通じて、技術革新が市場競争に与える影響と競争環境の変化を解読します
競争環境と事業動向の把握
製品タイプ別、用途別、地域・国別の観点からニューロテクノロジーデバイス市場のセグメント構造を整理します。各地域の需要構成と成長特性を比較分析し、各細分領域が市場全体の成長に与える貢献度と相互関連性を明確にします
成長要因・課題・リスクの分析
ニューロテクノロジーデバイス市場の成長を支える主要ドライバーを整理するとともに、業界特有の課題や潜在的リスクを分析します。原材料調達、供給システム、事業運営における不確実性を踏まえ、サプライチェーン及び事業レジリエンス強化の方向性についても考察します
将来トレンドと市場展望
ニューロテクノロジーデバイス市場の中長期的な成長トレンドと将来の発展シナリオを提示します。持続的成長を実現するための重要な成功要因を整理し、今後の市場参入企業や既存プレイヤーの戦略的意思決定に参考となる視点を提供いたします
Description
According to YH Research, the global market for Neurotechnology Device should grow from US$ 14330 million in 2025 to US$ 23160 million by 2032, with a CAGR of 7.1% for the period of 2026-2032.
The strategic recalibration of 2025 U.S. tariff mechanisms is redefining global economic governance norms. This study deciphers the transmission mechanisms of tariff escalation pathways and global policy responses on corporate investment strategies, regional trade networks, and critical material supply architectures.
Neurotechnology is any technology that has a fundamental influence on how people understand the brain and various aspects of consciousness, thought, and higher order activities in the brain. It also includes technologies that are designed to improve and repair brain function and allow researchers and clinicians to visualize the brain. The digital health sector matures from basic tracking apps into highly regulated medical devices, right now there is a bleeding edge technologies being developed that blur the lines between computers and biology and a growing share of these startups are beginning to target the brain. The burgeoning field of neurotechnology involves brain-machine interfaces, neuroproteins, neurostimulation, neuromonitoring, and implantable devices intended to not only augment nervous system activity, but expand its capabilities.
The global neurotechnology device market refers to the industry involved in the development, manufacturing, distribution, and usage of devices and technologies that are used in the diagnosis, treatment, and management of neurological disorders and conditions. Neurotechnology devices encompass a wide range of products, including neurostimulation devices, neurofeedback devices, brain-computer interfaces, neurodiagnostic devices, and neuroprosthetics. Here’s an overview of the market:
Market Overview: The neurotechnology device market is a rapidly growing sector within the broader medical device industry. It encompasses a diverse range of devices and technologies that aim to understand brain function, diagnose neurological disorders, and provide therapeutic interventions for various neurological conditions.
Market Segmentation: The market can be segmented based on the type of device, including neurostimulation devices (such as deep brain stimulation, spinal cord stimulation, and transcranial magnetic stimulation devices), neurofeedback devices, brain-computer interfaces, neurodiagnostic devices (such as EEG, MRI, and CT scanning), and neuroprosthetics (such as cochlear implants and deep brain implants).
Neurological Conditions: Neurotechnology devices are used in the diagnosis and treatment of various neurological conditions, including epilepsy, Parkinson’s disease, Alzheimer’s disease, stroke, chronic pain, depression, and others. These devices aim to improve patient outcomes, enhance quality of life, and potentially restore lost neurological function.
Technological Advancements: Advances in neuroscience, neuroimaging, computational algorithms, and miniaturization of devices have contributed to the rapid growth of the neurotechnology market. Innovations in neurostimulation techniques, real-time brain monitoring, wearable and implantable devices, and neurofeedback technologies are driving market expansion.
Key Players: The neurotechnology device market is highly competitive, with several established companies and emerging startups operating in the field. Key players include Medtronic, Abbott Laboratories, Boston Scientific, Cochlear Limited, NeuroPace, and others. These companies invest in research and development, clinical trials, and marketing to introduce new and improved neurotechnology devices.
Market Dynamics: Factors such as increasing prevalence of neurological disorders, growing aging population, rising awareness, technological advancements, and favorable reimbursement policies are driving the market growth. However, challenges such as high costs associated with devices, stringent regulatory processes, and ethical considerations in brain-computer interface technology can affect market progression.
Market Outlook: The global neurotechnology device market is expected to continue its growth trajectory in the coming years. Increasing investments in research and development, collaborations between academia and industry, and the focus on personalized medicine are likely to drive innovation and the introduction of advanced neurotechnology devices.
Ethical and Regulatory Considerations: The use of neurotechnology devices raises ethical concerns related to data privacy, informed consent, and potential misuse. Regulatory agencies closely monitor the safety and efficacy of these devices, ensuring adherence to quality standards and ethical principles.
This report studies and analyses global Neurotechnology Device status and future trends, helps the client to determine the Neurotechnology Device market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Neurotechnology Device, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2025 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Neurotechnology Device market size, history data 2021-2025, and forecast data 2026-2032, (US$ million) & (K Units)
(2) Global Neurotechnology Device sales, revenue, price by company, market share and industry ranking 2021-2026, (US$ million) & (K Units)
(3) Japan Neurotechnology Device sales, revenue, price by company, market share and industry ranking 2021-2026, (US$ million) & (K Units)
(4) Global Neurotechnology Device key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Neurotechnology Device key producing regions, capacity, production, and year over year growth
(6) Neurotechnology Device industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Abbott Laboratories
Advanced Bionics
Axonics Modulation Technologies
Boston Scientific Corp
Laborie
Cleveland Medical Devices
EndoStim
LivaNova
Medtronic
Natus Medical Incorporated
Neuronetics
NeuroSigma
Restorative Therapies
Zynex Medical
Cochlear Limited
Market segment by Type, covers
Neuroprosthetics
Neural Stimulators
Neurorehabilitation
Neurosensing
Market segment by Application, can be divided into
Parkinson's Disease
Cerebral Palsy
Cognitive Disorders
Epilepsy
Incontinence
Traumatic Brain Injury
Others
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Neurotechnology Device product scope, global sales quantity, value and average price, Japan sales quantity, value and average price, development opportunities, challenges, trends, and policies
Chapter 2: Global Neurotechnology Device market share and ranking of major manufacturers, sales quantity, revenue, average price, 2021-2026
Chapter 3: Japan Neurotechnology Device market share and ranking of major manufacturers, sales quantity, revenue, average price, 2021-2026
Chapter 4: Global key producing regions of Neurotechnology Device, percent & CAGR, 2021-2032
Chapter 5: Neurotechnology Device industry chain, upstream, medium-stream, and downstream
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2021-2032
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2021-2032
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2021-2032
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2021-2032
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin
Chapter 11: Conclusions
Table of Contents
1 Market Overview
1.1 Neurotechnology Device Definition
1.2 Global Neurotechnology Device Market Size and Forecast
1.2.1 By Consumption Value, Global Neurotechnology Device Market Size, 2021-2032
1.2.2 By Sales Quantity, Global Neurotechnology Device Market Size, 2021-2032
1.2.3 Global Neurotechnology Device Average Selling Price (ASP), 2021-2032
1.3 Japan Neurotechnology Device Market Size and Forecast
1.3.1 By Consumption Value, Japan Neurotechnology Device Market Size, 2021-2032
1.3.2 By Sales Quantity, Japan Neurotechnology Device Market Size, 2021-2032
1.3.3 Japan Neurotechnology Device Average Selling Price (ASP), 2021-2032
1.4 Share of Japan Neurotechnology Device Market with Respect to the Global Market
1.4.1 By Consumption Value, Japan Neurotechnology Device Market Share in Global, 2021-2032
1.4.2 By Sales Quantity, Japan Neurotechnology Device Market Share in Global, 2021-2032
1.4.3 Neurotechnology Device Market Size: Japan VS Global, 2021-2032
1.5 Neurotechnology Device Market Dynamics
1.5.1 Neurotechnology Device Market Drivers
1.5.2 Neurotechnology Device Market Restraints
1.5.3 Neurotechnology Device Industry Trends
1.5.4 Neurotechnology Device Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Neurotechnology Device, Global Market Share by Company, 2021-2026
2.2 By Sales Quantity of Neurotechnology Device, Global Market Share by Company, 2021-2026
2.3 Neurotechnology Device Average Selling Price (ASP) by Company, 2021-2026
2.4 Global Neurotechnology Device Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Neurotechnology Device Concentration Ratio
2.6 Global Neurotechnology Device Mergers & Acquisitions, Expansion Plans
2.7 Global Neurotechnology Device Manufacturers Product Type
2.8 Head Office and Neurotechnology Device Production Site of Key Manufacturer
2.9 Neurotechnology Device Capacity of Major Manufacturers and Future Plan
3 Japan Leading Manufacturers and Market Share
3.1 By Revenue of Neurotechnology Device, Japan Market Share by Company, 2021-2026
3.2 By Sales Quantity of Neurotechnology Device, Japan Market Share by Company, 2021-2026
3.3 Japan Neurotechnology Device Neurotechnology Device Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Neurotechnology Device Capacity, Output and Capacity Utilization, 2021-2032
4.2 Global Neurotechnology Device Capacity by Region
4.3 Global Neurotechnology Device Production & Forecast by Region, 2021 VS 2025 VS 2032
4.4 Global Neurotechnology Device Production by Region, 2021-2032
4.5 Global Neurotechnology Device Production Market Share & Forecast by Region, 2021-2032
5 Industry Chain Analysis
5.1 Neurotechnology Device Industry Chain
5.2 Neurotechnology Device Upstream Analysis
5.2.1 Neurotechnology Device Core Raw Materials
5.2.2 Main Manufacturers of Neurotechnology Device Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Neurotechnology Device Production Mode
5.6 Neurotechnology Device Procurement Model
5.7 Neurotechnology Device Industry Sales Model and Sales Channels
5.7.1 Neurotechnology Device Sales Model
5.7.2 Neurotechnology Device Typical Distributors
6 Sights by Type
6.1 Neurotechnology Device Classification by Type
6.1.1 Neuroprosthetics
6.1.2 Neural Stimulators
6.1.3 Neurorehabilitation
6.1.4 Neurosensing
6.2 by Type, Global Neurotechnology Device Consumption Value & CAGR, 2021 VS 2025 VS 2032
6.3 by Type, Global Neurotechnology Device Consumption Value, 2021-2032
6.4 by Type, Global Neurotechnology Device Sales Quantity, 2021-2032
6.5 by Type, Global Neurotechnology Device Average Selling Price (ASP), 2021-2032
7 Sights by Application
7.1 Neurotechnology Device Segment by Application
7.1.1 Parkinson's Disease
7.1.2 Cerebral Palsy
7.1.3 Cognitive Disorders
7.1.4 Epilepsy
7.1.5 Incontinence
7.1.6 Traumatic Brain Injury
7.1.7 Others
7.2 by Application, Global Neurotechnology Device Consumption Value & CAGR, 2021 VS 2025 VS 2032
7.3 by Application, Global Neurotechnology Device Consumption Value, 2021-2032
7.4 by Application, Global Neurotechnology Device Sales Quantity, 2021-2032
7.5 by Application, Global Neurotechnology Device Price, 2021-2032
8 Sales Sights by Region
8.1 By Region, Global Neurotechnology Device Consumption Value, 2021 VS 2025 VS 2032
8.2 By Region, Global Neurotechnology Device Consumption Value, 2021-2032
8.3 By Region, Global Neurotechnology Device Sales Quantity, 2021-2032
8.4 North America
8.4.1 North America Neurotechnology Device Market Size & Forecasts, 2021-2032
8.4.2 By Country, North America Neurotechnology Device Market Size Market Share
8.5 Europe
8.5.1 Europe Neurotechnology Device Market Size & Forecasts, 2021-2032
8.5.2 By Country, Europe Neurotechnology Device Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Neurotechnology Device Market Size & Forecasts, 2021-2032
8.6.2 By Country/Region, Asia Pacific Neurotechnology Device Market Size Market Share
8.7 South America
8.7.1 South America Neurotechnology Device Market Size & Forecasts, 2021-2032
8.7.2 By Country, South America Neurotechnology Device Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Neurotechnology Device Market Size & CAGR, 2021 VS 2025 VS 2032
9.2 By Country, Global Neurotechnology Device Consumption Value, 2021-2032
9.3 By Country, Global Neurotechnology Device Sales Quantity, 2021-2032
9.4 United States
9.4.1 United States Neurotechnology Device Market Size, 2021-2032
9.4.2 by Type, United States Neurotechnology Device Sales Quantity Market Share, 2025 VS 2032
9.4.3 by Application, United States Neurotechnology Device Sales Quantity Market Share, 2025 VS 2032
9.5 Europe
9.5.1 Europe Neurotechnology Device Market Size, 2021-2032
9.5.2 by Type, Europe Neurotechnology Device Sales Quantity Market Share, 2025 VS 2032
9.5.3 by Application, Europe Neurotechnology Device Sales Quantity Market Share, 2025 VS 2032
9.6 China
9.6.1 China Neurotechnology Device Market Size, 2021-2032
9.6.2 by Type, China Neurotechnology Device Sales Quantity Market Share, 2025 VS 2032
9.6.3 by Application, China Neurotechnology Device Sales Quantity Market Share, 2025 VS 2032
9.7 Japan
9.7.1 Japan Neurotechnology Device Market Size, 2021-2032
9.7.2 by Type, Japan Neurotechnology Device Sales Quantity Market Share, 2025 VS 2032
9.7.3 by Application, Japan Neurotechnology Device Sales Quantity Market Share, 2025 VS 2032
9.8 South Korea
9.8.1 South Korea Neurotechnology Device Market Size, 2021-2032
9.8.2 by Type, South Korea Neurotechnology Device Sales Quantity Market Share, 2025 VS 2032
9.8.3 by Application, South Korea Neurotechnology Device Sales Quantity Market Share, 2025 VS 2032
9.9 Southeast Asia
9.9.1 Southeast Asia Neurotechnology Device Market Size, 2021-2032
9.9.2 by Type, Southeast Asia Neurotechnology Device Sales Quantity Market Share, 2025 VS 2032
9.9.3 by Application, Southeast Asia Neurotechnology Device Sales Quantity Market Share, 2025 VS 2032
9.10 India
9.10.1 India Neurotechnology Device Market Size, 2021-2032
9.10.2 by Type, India Neurotechnology Device Sales Quantity Market Share, 2025 VS 2032
9.10.3 by Application, India Neurotechnology Device Sales Quantity Market Share, 2025 VS 2032
9.11 Middle East & Africa
9.11.1 Middle East & Africa Neurotechnology Device Market Size, 2021-2032
9.11.2 by Type, Middle East & Africa Neurotechnology Device Sales Quantity Market Share, 2025 VS 2032
9.11.3 by Application, Middle East & Africa Neurotechnology Device Sales Quantity Market Share, 2025 VS 2032
10 Manufacturers Profile
10.1 Abbott Laboratories
10.1.1 Abbott Laboratories Company Information, Head Office, Market Area, and Industry Position
10.1.2 Abbott Laboratories Neurotechnology Device Models, Specifications, and Application
10.1.3 Abbott Laboratories Neurotechnology Device Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.1.4 Abbott Laboratories Company Profile and Main Business
10.1.5 Abbott Laboratories Recent Developments
10.2 Advanced Bionics
10.2.1 Advanced Bionics Company Information, Head Office, Market Area, and Industry Position
10.2.2 Advanced Bionics Neurotechnology Device Models, Specifications, and Application
10.2.3 Advanced Bionics Neurotechnology Device Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.2.4 Advanced Bionics Company Profile and Main Business
10.2.5 Advanced Bionics Recent Developments
10.3 Axonics Modulation Technologies
10.3.1 Axonics Modulation Technologies Company Information, Head Office, Market Area, and Industry Position
10.3.2 Axonics Modulation Technologies Neurotechnology Device Models, Specifications, and Application
10.3.3 Axonics Modulation Technologies Neurotechnology Device Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.3.4 Axonics Modulation Technologies Company Profile and Main Business
10.3.5 Axonics Modulation Technologies Recent Developments
10.4 Boston Scientific Corp
10.4.1 Boston Scientific Corp Company Information, Head Office, Market Area, and Industry Position
10.4.2 Boston Scientific Corp Neurotechnology Device Models, Specifications, and Application
10.4.3 Boston Scientific Corp Neurotechnology Device Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.4.4 Boston Scientific Corp Company Profile and Main Business
10.4.5 Boston Scientific Corp Recent Developments
10.5 Laborie
10.5.1 Laborie Company Information, Head Office, Market Area, and Industry Position
10.5.2 Laborie Neurotechnology Device Models, Specifications, and Application
10.5.3 Laborie Neurotechnology Device Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.5.4 Laborie Company Profile and Main Business
10.5.5 Laborie Recent Developments
10.6 Cleveland Medical Devices
10.6.1 Cleveland Medical Devices Company Information, Head Office, Market Area, and Industry Position
10.6.2 Cleveland Medical Devices Neurotechnology Device Models, Specifications, and Application
10.6.3 Cleveland Medical Devices Neurotechnology Device Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.6.4 Cleveland Medical Devices Company Profile and Main Business
10.6.5 Cleveland Medical Devices Recent Developments
10.7 EndoStim
10.7.1 EndoStim Company Information, Head Office, Market Area, and Industry Position
10.7.2 EndoStim Neurotechnology Device Models, Specifications, and Application
10.7.3 EndoStim Neurotechnology Device Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.7.4 EndoStim Company Profile and Main Business
10.7.5 EndoStim Recent Developments
10.8 LivaNova
10.8.1 LivaNova Company Information, Head Office, Market Area, and Industry Position
10.8.2 LivaNova Neurotechnology Device Models, Specifications, and Application
10.8.3 LivaNova Neurotechnology Device Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.8.4 LivaNova Company Profile and Main Business
10.8.5 LivaNova Recent Developments
10.9 Medtronic
10.9.1 Medtronic Company Information, Head Office, Market Area, and Industry Position
10.9.2 Medtronic Neurotechnology Device Models, Specifications, and Application
10.9.3 Medtronic Neurotechnology Device Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.9.4 Medtronic Company Profile and Main Business
10.9.5 Medtronic Recent Developments
10.10 Natus Medical Incorporated
10.10.1 Natus Medical Incorporated Company Information, Head Office, Market Area, and Industry Position
10.10.2 Natus Medical Incorporated Neurotechnology Device Models, Specifications, and Application
10.10.3 Natus Medical Incorporated Neurotechnology Device Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.10.4 Natus Medical Incorporated Company Profile and Main Business
10.10.5 Natus Medical Incorporated Recent Developments
10.11 Neuronetics
10.11.1 Neuronetics Company Information, Head Office, Market Area, and Industry Position
10.11.2 Neuronetics Neurotechnology Device Models, Specifications, and Application
10.11.3 Neuronetics Neurotechnology Device Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.11.4 Neuronetics Company Profile and Main Business
10.11.5 Neuronetics Recent Developments
10.12 NeuroSigma
10.12.1 NeuroSigma Company Information, Head Office, Market Area, and Industry Position
10.12.2 NeuroSigma Neurotechnology Device Models, Specifications, and Application
10.12.3 NeuroSigma Neurotechnology Device Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.12.4 NeuroSigma Company Profile and Main Business
10.12.5 NeuroSigma Recent Developments
10.13 Restorative Therapies
10.13.1 Restorative Therapies Company Information, Head Office, Market Area, and Industry Position
10.13.2 Restorative Therapies Neurotechnology Device Models, Specifications, and Application
10.13.3 Restorative Therapies Neurotechnology Device Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.13.4 Restorative Therapies Company Profile and Main Business
10.13.5 Restorative Therapies Recent Developments
10.14 Zynex Medical
10.14.1 Zynex Medical Company Information, Head Office, Market Area, and Industry Position
10.14.2 Zynex Medical Neurotechnology Device Models, Specifications, and Application
10.14.3 Zynex Medical Neurotechnology Device Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.14.4 Zynex Medical Company Profile and Main Business
10.14.5 Zynex Medical Recent Developments
10.15 Cochlear Limited
10.15.1 Cochlear Limited Company Information, Head Office, Market Area, and Industry Position
10.15.2 Cochlear Limited Neurotechnology Device Models, Specifications, and Application
10.15.3 Cochlear Limited Neurotechnology Device Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.15.4 Cochlear Limited Company Profile and Main Business
10.15.5 Cochlear Limited Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table of Figures
List of Tables Table 1. Neurotechnology Device Consumption Value & CAGR: Japan VS Global, 2021-2032, US$ Million Table 2. Neurotechnology Device Market Restraints Table 3. Neurotechnology Device Market Trends Table 4. Neurotechnology Device Industry Policy Table 5. Global Neurotechnology Device Revenue by Company, 2021-2026, US$ million, Ranked Based on Revenue in 2025 Table 6. Global Neurotechnology Device Revenue Share by Company, 2021-2026, Ranked by Data of 2025 Table 7. Global Neurotechnology Device Sales Quantity by Company, (2021-2026) & (K Units), Ranked Based on Sales in 2025 Table 8. Global Neurotechnology Device Sales Quantity Market Share by Company, 2021-2026, Ranked by Data of 2025 Table 9. Global Neurotechnology Device Average Selling Price (ASP) by Company, (2021-2026) & (US$/Unit) Table 10. Global Neurotechnology Device Manufacturers Market Concentration Ratio (CR3 and HHI) Table 11. Global Neurotechnology Device Mergers & Acquisitions, Expansion Plans Table 12. Global Neurotechnology Device Manufacturers Product Type Table 13. Head Office and Neurotechnology Device Production Site of Key Manufacturer Table 14. Neurotechnology Device Capacity of Major Manufacturers and Future Plan Table 15. Japan Neurotechnology Device Revenue by Company, 2021-2026, US$ million, Ranked Based on Revenue in 2025 Table 16. Japan Neurotechnology Device Revenue Share by Company, 2021-2026, Ranked by Data of 2025 Table 17. Japan Neurotechnology Device Sales Quantity by Company, (2021-2026) & (K Units), Ranked Based on Sales in 2025 Table 18. Japan Neurotechnology Device Sales Quantity Market Share by Company, 2021-2026, Ranked by Data of 2025 Table 19. Global Neurotechnology Device Production & Forecast by Region, 2021 VS 2025 VS 2032, (K Units) Table 20. Global Neurotechnology Device Production by Region, 2021-2026, (K Units) Table 21. Global Neurotechnology Device Production Forecast by Region, 2027-2032, (K Units) Table 22. Global Key Players of Neurotechnology Device Upstream (Raw Materials) Table 23. Global Neurotechnology Device Typical Customers Table 24. Neurotechnology Device Typical Distributors Table 25. by Type, Global Neurotechnology Device Consumption Value & CAGR, 2021 VS 2025 VS 2032, US$ Million Table 26. by Application, Global Neurotechnology Device Consumption Value & CAGR, 2021 VS 2025 VS 2032, US$ Million Table 27. By Region, Global Neurotechnology Device Consumption Value, 2021 VS 2025 VS 2032, US$ Million Table 28. By Region, Global Neurotechnology Device Consumption Value, 2021-2032, US$ Million Table 29. By Region, Global Neurotechnology Device Sales Quantity, 2021-2032, (K Units) Table 30. By Country, Global Neurotechnology Device Consumption Value & CAGR, 2021 VS 2025 VS 2032, US$ Million Table 31. By Country, Global Neurotechnology Device Consumption Value, 2021-2032, US$ Million Table 32. By Country, Global Neurotechnology Device Consumption Value Market Share, 2021-2032 Table 33. By Country, Global Neurotechnology Device Sales Quantity, 2021-2032, (K Units) Table 34. By Country, Global Neurotechnology Device Sales Quantity Market Share, 2021-2032 Table 35. Abbott Laboratories Company Information, Head Office, Market Area, and Industry Position Table 36. Abbott Laboratories Neurotechnology Device Models, Specifications, and Application Table 37. Abbott Laboratories Neurotechnology Device Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026 Table 38. Abbott Laboratories Company Profile and Main Business Table 39. Abbott Laboratories Recent Developments Table 40. Advanced Bionics Company Information, Head Office, Market Area, and Industry Position Table 41. Advanced Bionics Neurotechnology Device Models, Specifications, and Application Table 42. Advanced Bionics Neurotechnology Device Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026 Table 43. Advanced Bionics Company Profile and Main Business Table 44. Advanced Bionics Recent Developments Table 45. Axonics Modulation Technologies Company Information, Head Office, Market Area, and Industry Position Table 46. Axonics Modulation Technologies Neurotechnology Device Models, Specifications, and Application Table 47. Axonics Modulation Technologies Neurotechnology Device Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026 Table 48. Axonics Modulation Technologies Company Profile and Main Business Table 49. Axonics Modulation Technologies Recent Developments Table 50. Boston Scientific Corp Company Information, Head Office, Market Area, and Industry Position Table 51. Boston Scientific Corp Neurotechnology Device Models, Specifications, and Application Table 52. Boston Scientific Corp Neurotechnology Device Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026 Table 53. Boston Scientific Corp Company Profile and Main Business Table 54. Boston Scientific Corp Recent Developments Table 55. Laborie Company Information, Head Office, Market Area, and Industry Position Table 56. Laborie Neurotechnology Device Models, Specifications, and Application Table 57. Laborie Neurotechnology Device Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026 Table 58. Laborie Company Profile and Main Business Table 59. Laborie Recent Developments Table 60. Cleveland Medical Devices Company Information, Head Office, Market Area, and Industry Position Table 61. Cleveland Medical Devices Neurotechnology Device Models, Specifications, and Application Table 62. Cleveland Medical Devices Neurotechnology Device Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026 Table 63. Cleveland Medical Devices Company Profile and Main Business Table 64. Cleveland Medical Devices Recent Developments Table 65. EndoStim Company Information, Head Office, Market Area, and Industry Position Table 66. EndoStim Neurotechnology Device Models, Specifications, and Application Table 67. EndoStim Neurotechnology Device Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026 Table 68. EndoStim Company Profile and Main Business Table 69. EndoStim Recent Developments Table 70. LivaNova Company Information, Head Office, Market Area, and Industry Position Table 71. LivaNova Neurotechnology Device Models, Specifications, and Application Table 72. LivaNova Neurotechnology Device Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026 Table 73. LivaNova Company Profile and Main Business Table 74. LivaNova Recent Developments Table 75. Medtronic Company Information, Head Office, Market Area, and Industry Position Table 76. Medtronic Neurotechnology Device Models, Specifications, and Application Table 77. Medtronic Neurotechnology Device Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026 Table 78. Medtronic Company Profile and Main Business Table 79. Medtronic Recent Developments Table 80. Natus Medical Incorporated Company Information, Head Office, Market Area, and Industry Position Table 81. Natus Medical Incorporated Neurotechnology Device Models, Specifications, and Application Table 82. Natus Medical Incorporated Neurotechnology Device Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026 Table 83. Natus Medical Incorporated Company Profile and Main Business Table 84. Natus Medical Incorporated Recent Developments Table 85. Neuronetics Company Information, Head Office, Market Area, and Industry Position Table 86. Neuronetics Neurotechnology Device Models, Specifications, and Application Table 87. Neuronetics Neurotechnology Device Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026 Table 88. Neuronetics Company Profile and Main Business Table 89. Neuronetics Recent Developments Table 90. NeuroSigma Company Information, Head Office, Market Area, and Industry Position Table 91. NeuroSigma Neurotechnology Device Models, Specifications, and Application Table 92. NeuroSigma Neurotechnology Device Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026 Table 93. NeuroSigma Company Profile and Main Business Table 94. NeuroSigma Recent Developments Table 95. Restorative Therapies Company Information, Head Office, Market Area, and Industry Position Table 96. Restorative Therapies Neurotechnology Device Models, Specifications, and Application Table 97. Restorative Therapies Neurotechnology Device Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026 Table 98. Restorative Therapies Company Profile and Main Business Table 99. Restorative Therapies Recent Developments Table 100. Zynex Medical Company Information, Head Office, Market Area, and Industry Position Table 101. Zynex Medical Neurotechnology Device Models, Specifications, and Application Table 102. Zynex Medical Neurotechnology Device Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026 Table 103. Zynex Medical Company Profile and Main Business Table 104. Zynex Medical Recent Developments Table 105. Cochlear Limited Company Information, Head Office, Market Area, and Industry Position Table 106. Cochlear Limited Neurotechnology Device Models, Specifications, and Application Table 107. Cochlear Limited Neurotechnology Device Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026 Table 108. Cochlear Limited Company Profile and Main Business Table 109. Cochlear Limited Recent Developments List of Figures Figure 1. Neurotechnology Device Picture Figure 2. Global Neurotechnology Device Consumption Value, (US$ million) & (2021-2032) Figure 3. Global Neurotechnology Device Sales Quantity, (K Units) & (2021-2032) Figure 4. Global Neurotechnology Device Average Selling Price (ASP), (2021-2032) & (US$/Unit) Figure 5. Japan Neurotechnology Device Consumption Value, (US$ million) & (2021-2032) Figure 6. Japan Neurotechnology Device Sales Quantity (K Units) & (2021-2032) Figure 7. Japan Neurotechnology Device Average Selling Price (ASP), (US$/Unit) & (2021-2032) Figure 8. By Consumption Value, Japan Neurotechnology Device Market Share of Global, 2021-2032 Figure 9. By Sales Quantity, Japan Neurotechnology Device Market Share of Global, 2021-2032 Figure 10. Global Neurotechnology Device Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2025 Figure 11. Japan Neurotechnology Device Key Participants, Market Share, 2025 Figure 12. Global Neurotechnology Device Capacity, Production and Capacity Utilization, 2021-2032 Figure 13. Global Neurotechnology Device Capacity Market Share by Region, 2025 VS 2032 Figure 14. Global Neurotechnology Device Production Market Share & Forecast by Region, 2021-2032 Figure 15. Neurotechnology Device Industry Chain Figure 16. Neurotechnology Device Procurement Model Figure 17. Neurotechnology Device Sales Model Figure 18. Neurotechnology Device Sales Channels, Direct Sales, and Distribution Figure 19. Neuroprosthetics Figure 20. Neural Stimulators Figure 21. Neurorehabilitation Figure 22. Neurosensing Figure 23. by Type, Global Neurotechnology Device Consumption Value, 2021-2032, US$ Million Figure 24. by Type, Global Neurotechnology Device Consumption Value Market Share, 2021-2032 Figure 25. by Type, Global Neurotechnology Device Sales Quantity, 2021-2032, (K Units) Figure 26. by Type, Global Neurotechnology Device Sales Quantity Market Share, 2021-2032 Figure 27. by Type, Global Neurotechnology Device Average Selling Price (ASP), 2021-2032, (US$/Unit) Figure 28. Parkinson's Disease Figure 29. Cerebral Palsy Figure 30. Cognitive Disorders Figure 31. Epilepsy Figure 32. Incontinence Figure 33. Traumatic Brain Injury Figure 34. Others Figure 35. by Application, Global Neurotechnology Device Consumption Value, 2021-2032, US$ Million Figure 36. by Application, Global Neurotechnology Device Revenue Market Share, 2021-2032 Figure 37. by Application, Global Neurotechnology Device Sales Quantity, 2021-2032, (K Units) Figure 38. by Application, Global Neurotechnology Device Sales Quantity Market Share, 2021-2032 Figure 39. by Application, Global Neurotechnology Device Price, 2021-2032, (US$/Unit) Figure 40. By Region, Global Neurotechnology Device Consumption Value Market Share, 2021-2032 Figure 41. By Region, Global Neurotechnology Device Sales Quantity Market Share, 2021-2032 Figure 42. North America Neurotechnology Device Consumption Value & Forecasts, 2021-2032, US$ Million Figure 43. By Country, North America Neurotechnology Device Consumption Value Market Share, 2025 Figure 44. Europe Neurotechnology Device Consumption Value & Forecasts, 2021-2032, US$ Million Figure 45. By Country, Europe Neurotechnology Device Consumption Value Market Share, 2025 Figure 46. Asia Pacific Neurotechnology Device Consumption Value & Forecasts, 2021-2032, US$ Million Figure 47. By Country/Region, Asia Pacific Neurotechnology Device Consumption Value Market Share, 2025 Figure 48. South America Neurotechnology Device Consumption Value & Forecasts, 2021-2032, US$ Million Figure 49. By Country, South America Neurotechnology Device Consumption Value Market Share, 2025 Figure 50. Middle East & Africa Neurotechnology Device Consumption Value & Forecasts, 2021-2032, US$ Million Figure 51. United States Neurotechnology Device Sales Quantity, 2021-2032, (K Units) Figure 52. by Type, United States Neurotechnology Device Sales Quantity Market Share, 2025 VS 2032 Figure 53. by Application, United States Neurotechnology Device Sales Quantity Market Share, 2025 VS 2032 Figure 54. Europe Neurotechnology Device Sales Quantity, 2021-2032, (K Units) Figure 55. by Type, Europe Neurotechnology Device Sales Quantity Market Share, 2025 VS 2032 Figure 56. by Application, Europe Neurotechnology Device Sales Quantity Market Share, 2025 VS 2032 Figure 57. China Neurotechnology Device Sales Quantity, 2021-2032, (K Units) Figure 58. by Type, China Neurotechnology Device Sales Quantity Market Share, 2025 VS 2032 Figure 59. by Application, China Neurotechnology Device Sales Quantity Market Share, 2025 VS 2032 Figure 60. Japan Neurotechnology Device Sales Quantity, 2021-2032, (K Units) Figure 61. by Type, Japan Neurotechnology Device Sales Quantity Market Share, 2025 VS 2032 Figure 62. by Application, Japan Neurotechnology Device Sales Quantity Market Share, 2025 VS 2032 Figure 63. South Korea Neurotechnology Device Sales Quantity, 2021-2032, (K Units) Figure 64. by Type, South Korea Neurotechnology Device Sales Quantity Market Share, 2025 VS 2032 Figure 65. by Application, South Korea Neurotechnology Device Sales Quantity Market Share, 2025 VS 2032 Figure 66. Southeast Asia Neurotechnology Device Sales Quantity, 2021-2032, (K Units) Figure 67. by Type, Southeast Asia Neurotechnology Device Sales Quantity Market Share, 2025 VS 2032 Figure 68. by Application, Southeast Asia Neurotechnology Device Sales Quantity Market Share, 2025 VS 2032 Figure 69. India Neurotechnology Device Sales Quantity, 2021-2032, (K Units) Figure 70. by Type, India Neurotechnology Device Sales Quantity Market Share, 2025 VS 2032 Figure 71. by Application, India Neurotechnology Device Sales Quantity Market Share, 2025 VS 2032 Figure 72. Middle East & Africa Neurotechnology Device Sales Quantity, 2021-2032, (K Units) Figure 73. by Type, Middle East & Africa Neurotechnology Device Sales Quantity Market Share, 2025 VS 2032 Figure 74. by Application, Middle East & Africa Neurotechnology Device Sales Quantity Market Share, 2025 VS 2032 Figure 75. Research Methodology Figure 76. Breakdown of Primary Interviews Figure 77. Bottom-up Approaches Figure 78. Top-down Approaches
お見積>
サンプルお申込み>
今すぐ購入>
PDFダウンロード>






